Item 9.01. Financial Statements and Exhibits

(a) Financial Statements of Business Acquired.

The audited financial statements of Jay Pharma, Inc. as of and for the years ended December 31, 2019 and 2018, together with the reports of Marcum LLP with respect thereto, are included as Exhibit 99.1 and are incorporated by reference herein. The unaudited condensed financial statements of Jay Pharma as of and for the nine months ended September 30, 2020 are included as Exhibit 99.2 hereto and are incorporated by reference herein.

(b) Pro Forma Financial Information.

The unaudited pro forma condensed combined statements of operations of the Company as of and for the year ended December 31 2019 and balance sheets and statements of operations for the nine months ended September 30, 2020 are included as Exhibit 99.3 hereto and are incorporated by reference herein.





(d) Exhibits.



Exhibit No.   Description

23.1            Consent of Marcum LLP
99.1            Audited financial statements of Jay Pharma, Inc. as of and for the
              years ended December 31, 2019 and 2018
99.2            Unaudited condensed financial statements of Jay Pharma, Inc. as of
              and for the nine months ended September 30, 2020
99.3            Unaudited condensed combined pro forma financial statements of
              Enveric Biosciences, Inc. as of and for the nine months ended
              September 30, 2020 and for the year ended December 31, 2019




                                     * * *

© Edgar Online, source Glimpses